To evaluate the effect p21, p53, TP53BP1 and p73 single nucleotide polymorphisms (SNPs) on the risk of ESCC, we conducted a hospital based case–control study. The gene discussed is TP53BP1; the disease is esophageal squamous cell carcinoma.